Vimarsana
Biggest News Aggregation in the World

Regulatory Pathways News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulatory Pathways. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulatory Pathways Today - Breaking & Trending Today

Impact of IRA Seen as ISPOR 2024 Heads to Atlanta - Vimarsana News

Impact of IRA Seen as ISPOR 2024 Heads to Atlanta

About 5000 leaders in health economics and outcomes research will gather for the 2024 meeting, which has the theme, "HEOR: A Transformative Force for Whole Health.”

Source: ajmc.com
AI Could Be Salvation or Doom of Our Institutions - Vimarsana News

AI Could Be Salvation or Doom of Our Institutions

Jan 10, 2024 // World in 2050 Senior Fellows met in December to discuss the impacts that AI will have on the health of our institutions in 2024 and beyond. Fellows highlighted how private actors empowered by AI could fill some roles usually reserved for institutions, as well as the role of democracies in creating healthy tech regulatory ecosystems.

It just got easier to navigate digital health product regulations - Vimarsana News

It just got easier to navigate digital health product regulations

Healthcare

GE Hitachi Formally Enters BWRX-300 SMR in UK Race for New Nuclear - Vimarsana News

GE Hitachi Formally Enters BWRX-300 SMR in UK Race for New Nuclear

GE Hitachi Nuclear Energy (GEH) has submitted a Generic Design Assessment (GDA) entry application for its BWRX-300 small modular reactor (SMR) to UK

Qihan Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Mee - Vimarsana News

Qihan Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Mee

HANGZHOU, China--(BUSINESS WIRE)--Hangzhou Qihan Biotechnology Co., Ltd, an innovative biotechnology company dedicated to applying genome editing technology to cell therapies and organ transplants, today announced preclinical data from its NK cell programs, presented during the poster session at the American Associa...